Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2674 studies found for:    Open Studies | "Metabolic Diseases"
Show Display Options
Rank Status Study
21 Recruiting UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Conditions: Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
Intervention: Biological: DUOC-01
22 Recruiting Study of the Reversibility of Glucose Intolerance Caused by Chronic Aspartame Consumption
Condition: Glucose Metabolism Disorder
Intervention: Other: Diet soda containing aspartame only
23 Recruiting Effects of Sucralose on Glucose Metabolism
Condition: Glucose Metabolism Disorders
Intervention: Other: Sucralose
24 Recruiting Impact of Blood Glucose at the First Trimester of Pregnant Women With Gestational Diabetes on Maternal and Fetal Outcomes and Metabolic Disorders: a Multi-central Prospective Cohort Study
Condition: Gestational Diabetes
Interventions: Dietary Supplement: Dietary control;   Drug: Insulin
25 Recruiting Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
Conditions: Metabolic Disease;   Seizures
Interventions: Drug: SGS-742;   Drug: Placebo
26 Not yet recruiting Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)
Condition: Hurler Syndrome, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy, Krabbe, Cerebral Adrenoleukodystrophy
Intervention: Drug: Umbilical cord blood transplantation with HSC835
27 Recruiting Individualized Prevention Strategy for High Risk Patients in Cardiovascular Disease: Prospective Cohort Study (Cardiovascular and Metabolic Disease Etiology Research Center - HIgh Risk Cohort) CMERC-HI
Condition: High Risk Cardiovascular Disease Patients
Intervention:
28 Recruiting Cardiometabolic HIIT-RT Study
Conditions: Metabolic Diseases;   Overweight;   Motor Activity
Interventions: Behavioral: High Intensity Interval;   Behavioral: Resistance training;   Behavioral: Plus: High Intensity Interval + Resistance Training;   Other: Usual clinical care
29 Recruiting Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort
Conditions: Metabolic Diseases;   Sleep Apnea;   Atherosclerosis
Intervention:
30 Recruiting Gut Microbiome Mediated Effects of Inulin Supplementation on Mineral and Bone Metabolism in Hemodialysis Patients
Conditions: Bone Diseases, Endocrine;   Nutritional and Metabolic Diseases
Interventions: Dietary Supplement: Inulin;   Dietary Supplement: Maltodextrin
31 Recruiting The Effect of Frequency and Duration of Breaks in Sitting Time on Metabolic Cardiovascular Risk Factors
Conditions: Sedentary Lifestyle;   Overweight and Obesity;   Metabolic Disease
Interventions: Behavioral: Control;   Behavioral: Breaker;   Behavioral: Prolonger;   Behavioral: Intermediate
32 Recruiting MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
33 Recruiting Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma
Conditions: Hypertriglyceridemia;   Cutaneous T Cell Lymphoma
Intervention: Other: oral glucose tolerance test (OGTT)
34 Not yet recruiting Effects of Sleeve Gastrectomy on Calcium Metabolism and the Skeleton
Conditions: Calcium Metabolism Disorders;   Morbid Obesity
Intervention:
35 Recruiting Nutritional Metabolomics: the Search for Dietary Exposure Variables 2
Conditions: Nutritional Disorders;   Metabolic Disorders
Intervention:
36 Recruiting Insulin Sensitivity, Glucose - and Fat Metabolism in Patients With Psoriasis
Conditions: Insulin Sensitivity;   Metabolism Disorder
Intervention: Other: Stabile Isotope tracers
37 Not yet recruiting Inflammatory Status of Visceral Adipose Tissue in Obese Patients Related to Periodontitis Severity
Conditions: Parodontitis;   Obesity;   Metabolism Disorders
Interventions: Other: SEVERE PERIODONTITIS;   Other: NO PERIODONTITIS
38 Recruiting The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
Conditions: Metabolic Disease;   Cardiovascular Disease;   Inflammation
Intervention:
39 Recruiting An Optimized Programming of Healthy Children (APPROACH)
Conditions: Pregnancy;   Obesity;   Gestational Age and Weight Conditions;   Maternal Care for Excessive Fetal Growth;   Metabolic Disorders
Interventions: Other: High-Protein/Low-GI Diet;   Other: Low-protein/High-GI Diet
40 Recruiting Metabolic Complications Following Knee Injury in Young and Middle Aged Patients
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Sedentary Lifestyle
Interventions: Biological: Blood and Urine sampling;   Radiation: DXA scan;   Biological: OGTT

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.